One of the neuropathological hallmarks of Alzheimer's disease (AD) is the amyloid plaque, primarily composed of aggregated amyloidbeta (A␤) peptide. In vitro, A␤1-42, the major alloform of A␤ found in plaques, self-assembles into fibrils at micromolar concentrations and acidic pH. Such conditions do not exist in the extracellular fluid of the brain where the pH is neutral and A␤ concentrations are in the nanomolar range. Here, we show that extracellular soluble A␤ (sA␤) at concentrations as low as 1 nM was taken up by murine cortical neurons and neuroblastoma (SHSY5Y) cells but not by human embryonic kidney (HEK293) cells. Following uptake, A␤ accumulated in Lysotracker-positive acidic vesicles (likely late endosomes or lysosomes) where effective concentrations (>2.5 M) were greater than two orders of magnitude higher than that in the extracellular fluid (25 nM), as quantified by fluorescence intensity using laser scanning confocal microscopy. Furthermore, SHSY5Y cells incubated with 1 M A␤1-42 for several days demonstrated a time-dependent increase in intracellular high molecular weight (HMW) (>200 kDa) aggregates, which were absent in cells grown in the presence of A␤1-40. Homogenates from these A␤1-42-loaded cells were capable of seeding amyloid fibril growth. These results demonstrate that A␤ can be taken up by certain cells at low physiologically relevant concentrations of extracellular A␤, and then concentrated into endosomes/lysosomes. At high concentrations, vesicular A␤ aggregates to form HMW species which are capable of seeding amyloid fibril growth. We speculate that extrusion of these aggregates may seed extracellular amyloid plaque formation during AD pathogenesis.
A
lzheimer's disease (AD), the most common form of dementia in Western countries, involves progressive accumulation of amyloid deposits, neuronal loss, cognitive decline, and eventual death. Senile plaques, a key pathological feature of this disease, are composed primarily of the amyloid-beta (A␤) peptide, and are found throughout the brain (1) . A␤ (ranging in length from 39-42 amino acids) is derived from the proteolytic cleavage of an endogenous transmembrane protein known as the amyloid precursor protein (APP). The most common A␤ peptide found in senile plaques is the 42-residue peptide (A␤ ) (2) , which also shows the strongest propensity for spontaneous aggregation in solution (3) . It is widely believed that the aggregation and accumulation of this peptide is involved in disease pathogenesis.
A␤ is produced primarily by neurons and secreted into the brain extracellular space where it is normally found in a soluble state (4) . A variety of physiological processes, including those associated with neuronal activity, are related to A␤ synthesis and release into the extracellular space (5) (6) (7) . Under normal physiological conditions and in AD patients, the concentration of A␤ in brain extracellular fluid (interstitial fluid, ISF and cerebrospinal fluid, CSF) is low (10 Ϫ10 M-10 Ϫ9 M) (8) (9) (10) (11) (12) . This is important because in vitro studies suggest that the critical concentration for spontaneous aggregation of A␤ is in the M range (13, 14) . Therefore, A␤ concentrations in vivo would have to increase by at least three to four orders of magnitude for spontaneous aggregation to be feasible in the extracellular space. To span this large concentration gap, several potential mechanisms have been proposed. Effective concentration could be increased through membrane association (15) (16) (17) , macromolecular crowding (18) , specific interactions with protein complexes or chaperones, or specific covalent modifications (19) (20) (21) (22) (23) .
If preformed aggregates are introduced into the extracellular space, these species can act as seeds for amyloid formation, propagating amyloid growth at lower concentrations than that required for seed formation (24) . In this study, we explored the possibility that low concentrations of soluble A␤ can be taken up by cells and concentrated into acidic vesicles. The combination of low pH and high effective concentration in acidic vesicles appear to yield favorable conditions for the spontaneous aggregation of A␤.
Results
Uptake of Human A␤ into Late Endosomes/Lysosomes. A␤ (250 nM) labeled with fluorescein isothiocyanate (FITC-A␤ 1-42 ) was incubated with a variety of cell types for 24 h and then imaged using confocal microscopy. Uptake of FITC-A␤ was observed in vesicles of SHSY5Y neuroblastoma cells (Fig. 1A ) and murine cortical neurons (Fig. 1B) , but not in human embryonic kidney (HEK293) cells (Fig. 1C ). These observations, consistent with previously published findings (25) , suggest cellular specificity in the uptake of FITC-A␤ . Because of the ease of growth and manipulation (relative to primary neuronal cultures), SHSY5Y cells were used to perform further studies. SHSY5Y cells, incubated with 250 nM of FITC-A␤ , FITC-scrambled-A␤ , or FITC alone, demonstrated vesicular uptake with FITC-A␤ (Fig. 1F) but not FITC-scrambled-A␤ (Fig. 1E ) or FITC alone (Fig. 1D) , suggesting a sequence-specific uptake mechanism. Uptake of tetramethylrhodamine-A␤ 1-42 (TMR-A␤ ) was similar to that seen with FITC-A␤ (Fig. 2 A and D, and G) , indicating that uptake was not fluorophore-dependent. To identify the vesicles into which A␤ accumulated, TMR-A␤ 1-42 -loaded SHSY5Y cells were co-stained with LysoTracker, 30 min before imaging. All vesicles with TMR-A␤ 1-42 co-stained with LysoTracker and appeared to be a major subset of LysoTracker-positive vesicles (Fig. 2) , suggesting that that A␤ is taken up and trafficked into late endosomes or lysosomally derived vesicles.
Because fluorescein fluorescence is altered at low pH, we chose to use TMR (which is relatively insensitive to pH changes) for more quantitative studies of A␤ uptake. TMR-A␤ 1-42 uptake was both dose-( Fig. 3 A and B) and time-dependent ( Fig.  3C and Fig. S1 A) . Extracellular concentrations as low as 1 nM were sufficient to produce vesicular uptake within 24 h of incubation (Fig. 3A) . Furthermore, fluorescent vesicles were first apparent within 2 h after the addition of 250 nM TMR-A␤ to cell cultures ( Fig. 3C and Fig. S1 A) . Incubation with TMR alone did not result in cellular uptake throughout the concentration range examined (Fig. S1B) . Furthermore, cell death was not detectable at all concentrations of TMR-A␤ 1-42 examined (Fig. S2) . To examine the fate of vesicular TMR-A␤ , after washout, SHSY5Y cells, loaded with TMR-A␤ for 24 h, were washed with medium free of TMR-A␤. Within 24-48 h after wash-out, few fluorescent vesicles remained ( Fig. 3D and Fig.  S1C ), suggesting rapid clearance/removal of TMR-A␤ after uptake and trafficking to late endosomes/lysosomes.
Concentration of A␤1-42 in Vesicles. SHSY5Y cells, grown in the presence of 25 nM TMR-A␤ 1-42 for 24 h, were imaged using confocal microscopy, and a pixel-by-pixel analysis of fluorescence intensity was performed to estimate the concentration of TMR-A␤ in vesicles. Fig. 4 shows fluorescence intensity on the z axis (in red) plotted above a high-power 2-D image of a group of SHSY5Y cells. To obtain a quantitative estimate of A␤ concentration inside the vesicles, pixel intensity was calibrated to known concentrations of free TMR (Fig. S3 A and B) . Twentynine vesicles from five different images taken at random positions within the culture dish were analyzed. Vesicles, between 1-3 m in diameter (consistent with late-endosomes/lysosomes), showed concentrations of TMR-A␤ 1-42 between 1 and 2.5 M. Two vesicles had concentrations well above 2.5 M, although this is above the upper limit of detection with the instrumentation used. These data represent a concentration increase of approximately 100-fold from that originally added to the culture medium. As will be discussed, this is almost certainly an underestimate of the actual concentration inside the vesicles. Given this approximately 100-fold difference in A␤ concentrations between the extracellular f luid and intracellular vesicles, SHSY5Y cells loaded with A␤ were examined for intracellular aggregates. SHSY5Y cells, grown in the presence of varying concentrations of unlabeled A␤ 1-42 (0-1,000 nM) for 5 days or in the presence of 1 M A␤ for varying periods of time (0-7 days), were washed, sonicated, and analyzed using agarose gel electrophoresis and immunoblotting with anti-A␤ antibodies (6E10 and 3D6, both N-terminal specific monoclonal antibodies). Tris-tricine gels showed high molecular weight (HMW) aggregates of A␤ (Ͼ200 kDa) in homogenates of cells grown in 1 M A␤ 1-42 for 5 days (Fig. 5A) . Moreover, HMW aggregates (Ͼ800 kDa) were detected in cell homogenates in a concentration- (Fig. 5B ) and time-dependent ( To determine whether HMW aggregates of A␤ that formed in intracellular vesicles can seed the formation of amyloid fibrils, control cells, cells loaded with unlabeled A␤ , and cells incubated with scrambled A␤ 1-42 were sonicated with SDS, and homogenates were incubated with 100 nM TMR-A␤ 1-42 at 37°C for 48 h. This concentration of A␤ is too low for spontaneous formation of fibrils within this time frame. A␤-loaded cell extracts induced the appearance of fluorescent precipitates, visible by microscopy ( Fig. 6E) , while extracts from cells grown in the absence of A␤ (Fig. 6D ) or in the presence of scrambled-A␤ (Fig. 6F) did not. Moreover, these same precipitates stained with Thioflavin-S, suggesting the formation of fibrils (Fig. 6H) . Again, extracts from cells grown in the absence of A␤ (Fig. 6G ) or in the presence of scrambled-A␤ (Fig. 6I ) failed to develop Thioflavin-S staining. Moreover, fresh A␤-loaded cell extract (before incubation with free A␤) did not show Thioflavin-S staining.
Discussion
A major conundrum in understanding spontaneous appearance of plaques in the AD brain is the gap between known extracellular A␤ concentrations in vivo (in the low nM range) and the concentration required for spontaneous aggregation in vitro (which is in the M range). This concentration gap spans three to four orders of magnitude. In this study, we find that SHSY5Y neuroblastoma cells and cortical neurons are capable of taking up and concentrating extracellular A␤ even at low, physiologically relevant concentrations. Starting with an extracellular concentration of 25 nM, we estimated the concentrations inside some intracellular vesicles to be at least 2.5 M. However, this is a likely a conservative estimate for several reasons. First, it is likely that the high concentrations within vesicles result in quenching of TMR fluorescence. Second, because fluorescent intensities were quantified in a single 2-D plane, it is unlikely that vesicles were entirely contained within the confocal beam volume. Off-target vesicles will result in concentration underestimations because fluorescence intensity decays as e Ϫr 2 where r is the radial distance from the point of maximal intensity. Third, our concentration calibration was performed on a homogeneous solution of fluorophores, under the assumption of uniform filling of the beam volume. Under experimental conditions, it is likely that a large number of fluorophores are contained within a volume smaller than that defined by a single pixel; this may be especially pronounced in an aggregate. Therefore, assuming the fluorophores are uniformly filling the beam volume can only lead to an underestimation. Finally, it is likely that the final concentration of A␤ added to the culture medium decreases with time due to the release of A␤-degrading proteases into the culture medium by neural cells (27) . Therefore, it is likely that the concentrations of A␤ in the intracellular vesicles may, in fact, be an order of magnitude higher than what we have estimated. This is in line with estimates of the critical concentration that support spontaneous aggregation of A␤ (28) . Therefore, we propose that certain cells may be capable of taking up A␤ and increasing its effective concentration by several orders of magnitude.
Most estimates for the concentration of A␤ in human cerebrospinal fluid (CSF) have been in the low nM range (0.1-1 nM) (8) (9) (10) (11) (12) . Although CSF concentrations of proteins do not necessarily reflect interstitial fluid (ISF) concentrations (the more relevant quantity), a recent study examining A␤ levels in human head trauma patients using microdialysis suggested that the concentration of A␤ is similar in the two pools (29) . At nM concentrations, it is believed that A␤ exists in soluble form, either as a monomer or low molecular weight oligomer (30) . Although intracellular aggregation was not detected when cells were incubated with extracellular A␤ at concentrations below 1 M, it must be noted that the time-line for the experiments was 5 days. It is likely that in vivo (during human disease pathogenesis) the time frame for accumulation of intracellular A␤ could be on the order of years to decades. Thus, a small imbalance in vesicular accumulation/degradation could lead to large increases in effective concentrations over the span of years and decades. Our in vitro experiments were designed to accelerate this process using higher concentrations of extracellular A␤ (1 M). Furthermore, this concentration differential between uptake and that required for aggregation underscores one of the major implications of this study: that uptake of A␤ occurs at physiologically relevant extracellular concentrations (1-10 nM), while intravesicular A␤ aggregation requires higher concentrations (1 M, extracellular). We demonstrate that this concentration differential can be achieved via a vesicular concentrating step involving a two to three order of magnitude increase in A␤ concentration. Previous studies have shown that high concen- trations of A␤ under acidic conditions (including those found in endosomal compartments) favor rapid aggregation (31, 32) . There is growing evidence that A␤ accumulates in vesicles in neurons before the development of amyloid plaques. In a variety of AD mouse models, vesicular A␤ immunostaining has been observed in cortical and hippocampal neurons before the deposition of amyloid plaques (33, 34) . Such vesicular A␤ immunostaining is absent in wildtype controls. Similar vesicular A␤ immunostaining has been reported in human AD brains (35, 36) , in AD-vulnerable brain regions from non-demented individuals, and in brains of young Down's Syndrome cases before the deposition of plaques (35, 37) . Although it has been speculated that this vesicular A␤ represents new A␤ synthesis from APP processing, an equally likely possibility is that this pool represents extracellular A␤ taken up by cells. Our studies focus on cellular uptake of A␤ and do not address cell-autonomous APP processing and A␤ synthesis.
The specific uptake of A␤ and A␤ 1-42 , but not scrambled-A␤, suggests that the uptake mechanism in SHSY5Y cells is receptor-mediated rather than via a non-specific mechanism like bulk uptake (TMR uptake was not observed). Although several A␤-binding receptors have been reported, the low density lipoprotein receptor-like protein-1 (LRP1) is likely a major neuronal A␤ receptor (38) . LRP1 can bind A␤ either directly (39) or via A␤ chaperones such as apoE (40) . A role for LRP1 in neuronal A␤ uptake is supported by a study demonstrating that TGF␤2-mediated intraneuronal accumulation of brain injected A␤ is markedly inhibited by LRP1 antagonist RAP (41) . Interestingly, HEK293 cells, which poorly internalized A␤ in this study, express very low levels of LRP1. The cellular uptake mechanisms that lead to intraneuronal A␤ accumulation require further investigation.
Why would A␤ be taken up and trafficked to endosomes/ lysosomes? The wash-out studies demonstrate that vesicular A␤ rapidly disappears after A␤ is washed out of the culture medium, suggesting an efficient clearance mechanism. However, when continuously exposed to extracellular A␤, vesicular A␤ accumulates. As vesicular A␤ concentrations increase, it is possible that the degradative capacity of the endosomal/lysosomal pathway may be overwhelmed, leading to the accumulation of A␤. Such accumulation may result in aggregation, with A␤ aggregates being degraded less efficiently than monomer or small oligomers (42) . Thus, one might speculate that disruption of this intracellular degradative pathway might lead to enhanced seed formation, and therefore more plaque deposition. In fact, gene deletion of a major lysosomal protease known to degrade A␤, cathepsin B, resulted in a dramatic increase in plaque pathogenesis (43) . Conversely, gene deletion of an endogenous inhibitor of cathepsin, cystatin C, reduced amyloid plaque load (44) , and this effect was eliminated in cathepsin B-knockout mice (43) . These studies add support to the idea that lysosomal proteolytic activity influences amyloid plaque pathogenesis.
Our data suggest that there is a difference between the aggregating behavior of A␤ and A␤ 1-42 even though both molecules are trafficked into the endosomes/lysosomes. In vitro experiments indicate that the critical concentration for A␤ aggregation is higher than that of A␤ (3) . This leads to the interesting possibility that aggregation protects A␤ 1-42 molecules from degradation in endosomes/lysosomes cleavage, whereas the competition between aggregation and degradation favors the latter for A␤ . If A␤ 1-42 molecules form aggregates that are less efficiently degraded in lysosomally-derived vesicles, then these aggregates could accumulate within cells. It is conceivable that these aggregates could then be released into the extracellular space either through, active exocytotic mechanisms, or through stress-induced cell death. Future studies will focus on in-vesicle aggregation and the fate of these aggregates so we may assess their role in aggregation-mediated pathogenesis in AD. Fluorescence Intensity Quantification. SHSY5Y cells incubated with 25 nM TMR-A␤ 1-42 for 24 h were imaged using the confocal microscope (at 543 nm excitation, 560 -615 nm bandpass emissions; 40ϫ water immersion objective). Pixel intensity at different laser powers was calibrated using known concentrations of free TMR (Fig. S3 A and B) . Six images from random regions of the culture dish were analyzed at five different excitation laser powers. In each image, four to five fluorescent vesicles, of size consistent with lysosomes (1-3 m in diameter), were selected inside different cells. For each point, four adjacent pixels centered about the most intense region of the vesicle were analyzed. The mean brightness was calculated and compared to the calibration curves to determine the concentration (Fig. S3 A and B) .
Cell Death Assay. Lactate Dehydrogenase (LDH) activity released into culture media by dying cells was assessed as an index of cell death, as previously described (45) .
Immunoblot. SHSY5Y cells were washed twice with cold PBS and detached with 0.05% trypsin/0.02%. The cell pellet was resuspended in cold Hanks' balanced salt solution (HBSS buffer), sonicated (Fisher Scientific) at level 3 using 1-s pulses ϫ 10, and centrifuged at 3,000 ϫ g for 5 min. The supernatant was loaded onto a 16.5% Tris-Tricine gel, transferred to a polyvinylidene difluoride (PVDF) membrane and probed with monoclonal antibody 6E10.
Agarose Gel Electrophoresis. Agarose (1.5% wt/vol) was melted in running buffer (20 mM Tris and 200 mM glycine) without SDS. While stirring the melted agarose, 10% (wt/vol) SDS solution was added (drop by drop to avoid local solidification of the agarose) to a 0.1% final SDS concentration. Cell extract was incubated for 7 min in sample buffer [60 mM Tris-HCl (pH 6.8), 5% glycerol, 2% SDS, and 0.05% bromophenol blue] at room temperature, resolved in a horizontal 1.5% agarose gel in a standard Tris/glycine/SDS buffer, transferred electrophoretically to a PVDF membrane, and probed with 6E10 or 3D6.
In Vitro Seeding. SHSY5Y cell pellets were resuspended in 2% SDS in PBS, sonicated (as above), and diluted 1:40 in PBS with 0.02% sodium azide and loaded into Labtek 8-well chambers to a final SDS concentration of 0.05%. 100 nM TMR-A␤1-42 was then added, and after incubation at 37°C for 48 h, images were acquired by fluorescence microscopy.
Thioflavin-S Staining. Culture wells were washed and incubated with 0.025% Thioflavin-S solution (in 50% ethanol) for 5 min, rinsed with 50% ethanol and water, and cover slipped for imaging. Histograms of pixel intensities were converted to cumulative distribution functions (CDFs). The ordinate shows the value CDF, while the abscissa shows pixel intensities. Five curves are shown, one for each of the laser excitation powers used. For specific value of the pixel intensity, the CDF value on the ordinate quantifies the probability of realizing that pixel intensity. The CDF was created from the pixel brightness values observed for 29 vesicles. (B) Vesicle-observed pixel intensities compared to average pixel intensities from dye solutions of known concentration. Vertical lines represent a range from 5-95% of the observed pixel intensities from the 29 vesicles analyzed as determined from the cumulative distribution functions in Fig. S1 . These are plotted against calibration curves showing the mean observed pixel intensities as a function of laser power for solutions of known concentrations of free TMR. As can be seen, the observed pixel intensities from the vesicles suggest that the intravesicular concentration is in the micromolar range. N terminus) . The immunoblot is identical to that seen using the 6E10 antibody (Fig. 5B) .
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